Detalhe da pesquisa
1.
Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-021 with reference bevacizumab.
BMC Cancer
; 22(1): 129, 2022 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35105329